Differences that matter: Major cytotoxic T cell-stimulating minor histocompatibility antigens

被引:70
|
作者
Malarkannan, S
Horng, T
Eden, P
Gonzalez, F
Shih, P
Brouwenstijn, N
Klinge, H
Christianson, G
Roopenian, D
Shastri, N [1 ]
机构
[1] Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol, Berkeley, CA 94720 USA
[2] Jackson Lab, Bar Harbor, ME 04609 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1016/S1074-7613(00)00033-9
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Despite thousands of genetic polymorphisms among MHC matched mouse strains, a few unknown histocompatibility antigens are targeted by the cytotoxic T cells specific for tissue grafts. We isolated the cDNA of a novel BALB.B antigen gene that defines the polymorphic H28 locus on chromosome 3 and yields the naturally processed ILENFPRL (IFL8) peptide for presentation by Kb MHC to C57BI/6 CTL. The CTL specific for the IFL8/K-b and our previously identified H60/K-b complexes represent a major fraction of the B6 anti-BALB.B immune response. The immunodominance of these antigens can be explained by their differential transcription in the donor versus the host strains and their expression in professional donor antigen-presenting cells.
引用
收藏
页码:333 / 344
页数:12
相关论文
共 50 条
  • [1] The major histocompatibility complex determines susceptibility to cytotoxic T cells directed against minor histocompatibility antigens
    Bevan, MJ
    JOURNAL OF IMMUNOLOGY, 2005, 175 (11): : 7069 - 7084
  • [2] MAJOR HISTOCOMPATIBILITY COMPLEX DETERMINES SUSCEPTIBILITY TO CYTOTOXIC T-CELLS DIRECTED AGAINST MINOR HISTOCOMPATIBILITY ANTIGENS
    BEVAN, MJ
    JOURNAL OF EXPERIMENTAL MEDICINE, 1975, 142 (06): : 1349 - 1364
  • [3] On the mechanisms of immunodominance in cytotoxic T lymphocyte responses to minor histocompatibility antigens
    Pion, S
    Fontaine, P
    Desaulniers, M
    Jutras, J
    Filep, JG
    Perreault, C
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (02) : 421 - 430
  • [4] Major vs minor histocompatibility antigens
    Roy, Denis Claude
    Perreault, Claude
    BLOOD, 2017, 129 (06) : 664 - 666
  • [5] ENGINEERING T CELL TARGETING MINOR HISTOCOMPATIBILITY ANTIGENS
    Masroori, N.
    Minguy, A.
    Sawchyn, C.
    Mathieu, C.
    Trottier, J.
    Bastien, J.
    Sanchez-Dardon, J.
    Dave, V.
    Mallette, F.
    Roy, D.
    CYTOTHERAPY, 2023, 25 (06) : S238 - S239
  • [6] Synergistic suppression of T cell responses by chloroquine and tacrolimus to minor and major histocompatibility antigens.
    Schultz, KR
    Su, WN
    Bader, S
    Rempel, J
    HayGlass, KT
    EXPERIMENTAL HEMATOLOGY, 1998, 26 (08) : 778 - 778
  • [7] MAJOR AND MINOR HISTOCOMPATIBILITY ANTIGENS AS TARGETS FOR T CELL SUBSETS IN GRAFT VERSUS HOST REACTION
    WOLTERS, EAJ
    BRONS, NHC
    BENNER, R
    EXPERIMENTAL HEMATOLOGY, 1979, 7 : 99 - 99
  • [8] Minor antigens - major impact: The role of minor histocompatibility antigens in allogeneic hematopoietic stem cell transplantation
    Hudecek, M.
    Bartsch, K.
    Tschiedel, S.
    Niederwieser, D.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2008, 133 (28-29) : 1511 - 1516
  • [9] IMMUNE-RESPONSE TO MINOR HISTOCOMPATIBILITY ANTIGENS - AUGMENTATION BY MAJOR HISTOCOMPATIBILITY ANTIGENS
    SCHIERMAN, LW
    MCBRIDE, RA
    TRANSPLANTATION, 1972, 13 (02) : 97 - +
  • [10] MINOR HISTOCOMPATIBILITY ANTIGENS AS TARGETS FOR T-CELL IMMUNOTHERAPY
    Pilunov, A. M.
    Romaniuk, D. S.
    Efimov, G. A.
    Savchenko, V. G.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2021, 66 (03): : 322 - 345